Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

BTKi Resistance Mutations Pre-Test

How, when, and why might a treatment stop working? Learn about resistance mutations in chronic lymphocytic leukemia (CLL), specifically in BTK inhibitor drugs, to better understand the answers to these questions.

Take our brief pre-test to assess your current knowledge. Then, watch the discussion between Dr. Brian Koffman and Dr. Jennifer Woyach and download or print the handout. Finally, complete a follow-up test to see how much knowledge you’ve gained.

Sponosred by Pharmacyclics, An Abbvie company and Johnson and Johnson

Johnson & Johnson Logo - CLL Society